HUP0303310A2 - Csökkentett immunogenitású módosított ciliáris neurotrofikus faktor (CNTF) - Google Patents
Csökkentett immunogenitású módosított ciliáris neurotrofikus faktor (CNTF)Info
- Publication number
- HUP0303310A2 HUP0303310A2 HU0303310A HUP0303310A HUP0303310A2 HU P0303310 A2 HUP0303310 A2 HU P0303310A2 HU 0303310 A HU0303310 A HU 0303310A HU P0303310 A HUP0303310 A HU P0303310A HU P0303310 A2 HUP0303310 A2 HU P0303310A2
- Authority
- HU
- Hungary
- Prior art keywords
- neurotrophic factor
- cntf
- ciliary neurotrophic
- administered
- reduced immunogenicity
- Prior art date
Links
- 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 title abstract 2
- 102100031614 Ciliary neurotrophic factor Human genes 0.000 title abstract 2
- 101150030072 CNTF gene Proteins 0.000 title 1
- 230000005847 immunogenicity Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000004048 modification Effects 0.000 abstract 2
- 238000012986 modification Methods 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 101000993364 Homo sapiens Ciliary neurotrophic factor Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A találmány tárgyát különösen embereknek beadandó, és különösenterápiás alkalmazású polipeptidek képezik. A polipeptidek módosítottpolipeptidek, amelyekben a módosítás a polipeptid csökkentett hajlamáteredményezi immunválasz kiváltására emberi személynek történő beadásesetén. A találmány tárgya különösen humán ciliáris neurotrofikusfaktor módosítása, olyan CNTF fehérjéket eredményezve, amelyeklényegében nem immunogének, vagy kevésbé immunogének, mint bármilyenmódosítatlan társuk, amikor in vivo beadják azokat. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01105089 | 2001-03-02 | ||
| PCT/EP2002/002084 WO2002070698A2 (en) | 2001-03-02 | 2002-02-27 | Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0303310A2 true HUP0303310A2 (hu) | 2003-12-29 |
Family
ID=8176647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0303310A HUP0303310A2 (hu) | 2001-03-02 | 2002-02-27 | Csökkentett immunogenitású módosított ciliáris neurotrofikus faktor (CNTF) |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040087503A1 (hu) |
| EP (1) | EP1379655A2 (hu) |
| JP (1) | JP2004529629A (hu) |
| KR (1) | KR20030081480A (hu) |
| CN (1) | CN1494593A (hu) |
| BR (1) | BR0207705A (hu) |
| CA (1) | CA2439682A1 (hu) |
| HU (1) | HUP0303310A2 (hu) |
| MX (1) | MXPA03007839A (hu) |
| PL (1) | PL362704A1 (hu) |
| RU (1) | RU2003129069A (hu) |
| WO (1) | WO2002070698A2 (hu) |
| ZA (1) | ZA200307678B (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005014641A2 (en) * | 2003-07-09 | 2005-02-17 | Xencor, Inc. | Ciliary neurotrophic factor variants |
| WO2005033137A1 (en) * | 2003-09-30 | 2005-04-14 | Regeneron Pharmaceuticals, Inc. | Modified ciliary neurotrophic factor polypeptides with reduced antigenicity |
| US8592374B2 (en) | 2007-03-16 | 2013-11-26 | Research Foundation For Mental Hygiene, Inc. | Neurotrophic peptides |
| EP2009103A1 (en) | 2007-03-16 | 2008-12-31 | Ebewe Pharma Ges.m.b.H. Nfg. KG | Neurotrophic peptides |
| US20090010966A1 (en) * | 2007-06-21 | 2009-01-08 | Angelica Therapeutics, Inc. | Modified diphtheria toxins |
| EP2268297A4 (en) * | 2008-02-29 | 2011-11-16 | Angelica Therapeutics Inc | MODIFIED TOXINS |
| DE102011104822A1 (de) | 2011-06-18 | 2012-12-20 | Christian-Albrechts-Universität Zu Kiel | Ciliary-Neutrophic-Factor-Varianten |
| US10059750B2 (en) | 2013-03-15 | 2018-08-28 | Angelica Therapeutics, Inc. | Modified toxins |
| JP6840668B2 (ja) * | 2014-11-14 | 2021-03-10 | ディ.イー.ショー リサーチ, エルエルシーD.E.Shaw Research, Llc | 結合された粒子間の相互作用の抑制 |
| KR102667654B1 (ko) * | 2016-12-06 | 2024-05-22 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 섬모 신경영양 인자 수용체 리간드-결합제 및 이의 사용 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593857A (en) * | 1991-08-23 | 1997-01-14 | Scios Inc. | Production of homogeneous truncated CNTF |
| JPH07503128A (ja) * | 1991-11-11 | 1995-04-06 | フィディーア・ソシエタ・ペル・アチオニ | ヒト毛様体ニューロン親和性因子の先端欠失型および突然変異タンパク質型の合成と精製 |
| US5939534A (en) * | 1993-12-29 | 1999-08-17 | Sumitomo Pharmaceuticals Company, Limited | Factors mutated in the D1 cap region |
| IT1288388B1 (it) * | 1996-11-19 | 1998-09-22 | Angeletti P Ist Richerche Bio | Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia |
| CN1387568A (zh) * | 1999-08-13 | 2002-12-25 | 里珍纳龙药品有限公司 | 修饰的睫状神经营养因子及其制备方法和使用方法 |
-
2002
- 2002-02-27 US US10/469,837 patent/US20040087503A1/en not_active Abandoned
- 2002-02-27 PL PL02362704A patent/PL362704A1/xx unknown
- 2002-02-27 CA CA002439682A patent/CA2439682A1/en not_active Abandoned
- 2002-02-27 EP EP02724185A patent/EP1379655A2/en not_active Withdrawn
- 2002-02-27 CN CNA028058666A patent/CN1494593A/zh active Pending
- 2002-02-27 HU HU0303310A patent/HUP0303310A2/hu unknown
- 2002-02-27 WO PCT/EP2002/002084 patent/WO2002070698A2/en not_active Application Discontinuation
- 2002-02-27 MX MXPA03007839A patent/MXPA03007839A/es unknown
- 2002-02-27 JP JP2002570723A patent/JP2004529629A/ja not_active Withdrawn
- 2002-02-27 RU RU2003129069/13A patent/RU2003129069A/ru not_active Application Discontinuation
- 2002-02-27 KR KR10-2003-7011480A patent/KR20030081480A/ko not_active Application Discontinuation
- 2002-02-27 BR BR0207705-1A patent/BR0207705A/pt not_active IP Right Cessation
-
2003
- 2003-10-01 ZA ZA200307678A patent/ZA200307678B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002070698A2 (en) | 2002-09-12 |
| PL362704A1 (en) | 2004-11-02 |
| MXPA03007839A (es) | 2003-12-08 |
| CN1494593A (zh) | 2004-05-05 |
| EP1379655A2 (en) | 2004-01-14 |
| CA2439682A1 (en) | 2002-09-12 |
| US20040087503A1 (en) | 2004-05-06 |
| RU2003129069A (ru) | 2005-04-20 |
| WO2002070698A3 (en) | 2003-11-20 |
| JP2004529629A (ja) | 2004-09-30 |
| KR20030081480A (ko) | 2003-10-17 |
| BR0207705A (pt) | 2004-03-23 |
| ZA200307678B (en) | 2004-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303534A2 (hu) | Csökkent immunogenitású módosított interferon-béta | |
| HUP0401534A2 (hu) | Módosított humán IX. faktor | |
| BR0207016A (pt) | Fator neurotrófico derivado de cérebro humano modificado (bdnf) com imunogenicidade reduzida | |
| BR0207283A (pt) | Anticorpos anti-egfr modificados com imunogenicidade reduzida | |
| HUP0303310A2 (hu) | Csökkentett immunogenitású módosított ciliáris neurotrofikus faktor (CNTF) | |
| BR0207819A (pt) | Proteìna, citocina, il-13 humano mutado, polinucleotìdeo, vetor, hospedeiro, composição farmacêutica, uso de uma proteìna, métodos para o tratamento de profilaxia de doença mediada por il-13, e para a preparação de uma proteìna | |
| HUP0303309A2 (hu) | Csökkentett immunogenitású módosított interferon-alfa | |
| IS2670B (is) | Bóluefni og notkun þar á til meðhöndlunar á blandaðri hreyfitaugahrörnun | |
| WO2002062833A3 (en) | Modified leptin with reduced immunogenicity | |
| WO2002062843A3 (en) | Modified erythropoietin (epo) with reduced immunogenicity | |
| HUP0303429A2 (hu) | Csökkent immunogenitású módosított granulocita-makrofág kolóniastimuláló faktor (GM-CSF) | |
| IL151097A0 (en) | Tumour-specific animal proteins | |
| HUP0400698A2 (hu) | Csökkentett immunogenitású módosított interleukin-1-receptor-antagonista (IL-1RA) | |
| DE69828801D1 (de) | Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus | |
| WO2004035602A3 (en) | Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines | |
| HUP0400340A2 (hu) | Polipeptidek immunogenitásának csökkentésére szolgáló eljárások | |
| HUP0303430A2 (hu) | Csökkentett immunogenitású, módosított protamin | |
| HUP0402334A2 (hu) | Módosított humán növekedési hormon | |
| HUP0401593A2 (hu) | A PTX3 hosszú pentraxin alkalmazása gyógyhatású készítmény előállítására autoimmun betegségek megelőzésére és kezelésére | |
| HUP0401121A2 (hu) | Csökkentett immunogenitású, módosított trombopoietin (TPO) | |
| WO2001051511A3 (de) | Rekombinante herstellung von humanen histon 1-subtypen sowie deren verwendung für therapeutische zwecke | |
| HUP0402041A2 (hu) | Csökkentett immunogenitású, módosított granulocita-kolonizációt stimuláló faktor (G-CSF) | |
| DE60036199D1 (de) | Proteaseresistente flint-analoge | |
| BR0207017A (pt) | Fator de crescimento ceratinócito modificado (kgf) com imunogenicidade reduzida | |
| IL158152A0 (en) | Osteoprotegerin in milk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |